Cerecor Inc (CERC)
Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.
Cerecor Reports Second Quarter 2021 Financial Results and Provides Business Updates
Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology Finance
Achieved performance milestone with positive initial results from its Phase 1b trial of CERC-002 in moderate-to- severe Crohn’s Disease who had previously failed three or more lines of biologics therapies, including anti-TNF alpha treatments
Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-oncology Targets
Cerecor completes divestiture of non-core neurology pipeline assets as it increases its focus on immunology, immuno-oncology, and rare genetic disorders
First Week of August 20th Options Trading For Cerecor (CERC)
Cerecor Enters Into $35 Million Debt Financing Agreement With Horizon Technology Finance
First Week of CERC January 2022 Options Trading
Investors in Cerecor Inc (CERC) saw new options begin trading this week, for the January 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Cerecor to Participate in Upcoming Investor Conferences
Snatch This Bargain Even Cheaper Than Interim CFO Sullivan Did
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 10, Cerecor Inc's Interim CFO, Christopher Ryan Sullivan, invested $11,606.41 into 5,095 shares of CERC, for a cost per share of $2.28..
Cerecor Reports First Quarter 2021 Financial Results and Provides Business Updates
Announced CERC-002 received Fast Track Designation from the U.S. Food and Drug Administration, following positive Phase 2 clinical trial for the t...
Cerecor Reports First Quarter 2021 Financial Results and Provides Business Updates
Top Penny Stocks to Buy Moving in Premarket? Check These 3 Out
These 3 penny stocks made big moves in pre-market trading; are they worth it?